Researchers at the IU Simon Comprehensive Cancer Center are transforming the future of cancer treatment with advances in immunotherapy. Your support is vital to helping us continue making the greatest possible progress in this critical area of medicine — and the most meaningful impact on patient lives.
Building hope for defeating the toughest diseases
Building a pipeline for immunotherapy breakthroughs
The Brown Center for Immunotherapy is translating research into products to treat patients on clinical trials. Our pipeline includes:
- Cellular therapy products that include CAR T-cell for multiple cancers and other diseases
- Experimental peptides to block or activate immune cells
- Monoclonal antibodies to target specific tumors
5Laboratories
3Research Cores
50+Team Members
Nobody believed 20 years ago that immunotherapy would be central to curing cancer. We’re not there yet, but we’re on our way.
Kelvin Lee, MD — Director, IU Simon Comprehensive Cancer Center
Simon Says: Immunotherapy 101
As part of our monthly Simon Says video series, Mateusz Opyrchal, MD, PhD, Vera Bradley Foundation Scholar in Breast Cancer Discovery, and Huda Salman, MD, PhD, executive director of the Brown Center for Immunotherapy, break down how immunotherapy works and its possibilities for cancer patients. Kelvin Lee, MD, director of the IU Simon Comprehensive Cancer Center, moderates.
The spirit of medicine—and philanthropy
The Brown Center for Immunotherapy was established in December 2016 with a $30 million gift from Indianapolis entrepreneur and IU School of Medicine alumnus Don Brown.
Your philanthropic gift will help the Brown Center for Immunotherapy continue to make a meaningful impact on patient lives.
Support our research
Donor support is crucial to advancing discoveries that will have the most meaningful impact on life-changing immunotherapies.
